Pentobarbital Half-Life
The elimination half-life of pentobarbital in adults ranges from 15 to 48 hours, with most sources citing 15-50 hours. 1, 2
Pharmacokinetic Details
According to the EXTRIP (Extracorporeal Treatments in Poisoning) Workgroup guidelines, pentobarbital is classified as a short-acting barbiturate with the following key pharmacokinetic parameters 1:
- Elimination half-life: 15-48 hours
- Volume of distribution: 0.5-1.0 L/kg
- Protein binding: 35-70%
- Duration of action: 3-4 hours (despite the longer half-life)
The FDA drug label confirms this range, stating "the plasma half-life for pentobarbital in adults is 15 to 50 hours and appears to be dose dependent." 2
Clinical Context and Variability
Factors Affecting Half-Life
The half-life demonstrates significant inter-individual variability and is influenced by:
- Dose dependency: Higher doses may prolong elimination 2
- Clinical condition: In severe head trauma patients receiving high-dose pentobarbital infusions, the mean half-life was notably shorter at 15.6 ± 3.9 hours compared to healthy controls (22.3 ± 4.0 hours) 3
- Renal function: Interestingly, renal failure does not significantly alter pentobarbital elimination, as it is metabolized almost exclusively hepatically with less than 5% excreted unchanged in urine 1, 4
Metabolism and Clearance
Pentobarbital undergoes nearly exclusive hepatic metabolism via the cytochrome P450 enzyme system 1. Key clearance parameters include:
- Total endogenous clearance: 18-39 mL/min
- Hepatic clearance: 18-37 mL/min
- Renal clearance: 0.2-2 mL/min (minimal)
Important clinical caveat: Pentobarbital induces hepatic microsomal enzymes and exhibits auto-induction with chronic use, leading to tolerance. However, tolerance develops to sedative effects but NOT to lethal respiratory depression concentrations—chronic users can tolerate higher doses but not higher serum concentrations before life-threatening toxicity occurs 1.